NASDAQ:BIIB
Biogen Inc.
- Stock
Share Trends
Recent Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Singhal Priya Head of Development Common Stock | 2024-04-03 | -93 −1.87% |
Murphy Nicole Head of Pharm Ops and Tech Common Stock | 2024-04-03 | 123 1.29% |
Singhal Priya Head of Development Common Stock | 2024-02-26 | -262 −5.09% |
Singhal Priya Head of Development Common Stock | 2024-02-21 | 632 13.99% |
Kramer Robin Chief Accounting Officer Common Stock | 2024-02-21 | 949 17.98% |
Largest Transactions
| Reporter | Filed at | Change (shares) |
|---|---|---|
Denner Alexander J Director Common Stock | 2019-05-02 | 118.34K 22.56% |
Denner Alexander J Director Common Stock | 2019-02-01 | 62.80K 13.60% |
Vounatsos Michel Chief Executive Officer Common Stock | 2021-01-29 | 16.34K 46.95% |
Vounatsos Michel Chief Executive Officer Common Stock | 2022-01-21 | 10.59K 19.96% |
Sherwin Stephen A Director Common Stock | 2020-03-12 | 9.84K 175.97% |
Transaction Log
| Filing Date | Transaction Date | Reporter | Title | Post Shares | Quantity | T | Stock Class | USD |
|---|---|---|---|---|---|---|---|---|
2024-04-03 | 2024-04-01 | Murphy Nicole | Head of Pharm Ops and Tech | 9.75K | 240 | M | Common Stock | 0 |
2024-04-03 | 2024-04-02 | Singhal Priya | Head of Development | 4.89K | 93 | S | Common Stock | -19.82K |
2024-04-03 | 2024-04-01 | Murphy Nicole | Head of Pharm Ops and Tech | 9.63K | 117 | F | Common Stock | -25.14K |
2024-02-26 | 2024-02-22 | Singhal Priya | Head of Development | 4.89K | 262 | S | Common Stock | -57.96K |
2024-02-21 | 2024-02-16 | Alexander Susan H | EVP Chief Legal Officer | 52.46K | 1.61K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Izzar Rachid | Head of Global Product Strat. | 10.01K | 1.37K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Kramer Robin | Chief Accounting Officer | 6.19K | 914 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Alexander Susan H | EVP Chief Legal Officer | 52.51K | 3.42K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Murphy Nicole | Head of Pharm Ops and Tech | 9.61K | 404 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Alexander Susan H | EVP Chief Legal Officer | 51.68K | 781 | F | Common Stock | -171.10K |
2024-02-21 | 2024-02-16 | Singhal Priya | Head of Development | 5.43K | 389 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Gregory Ginger | EVP, Human Resources | 13.58K | 729 | F | Common Stock | -159.71K |
2024-02-21 | 2024-02-16 | Mcdonnell Michael R | EVP, Chief Financial Officer | 20.69K | 4.57K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Gregory Ginger | EVP, Human Resources | 12.81K | 1.53K | F | Common Stock | -336.29K |
2024-02-21 | 2024-02-16 | Kramer Robin | Chief Accounting Officer | 6.35K | 431 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Alexander Susan H | EVP Chief Legal Officer | 50.85K | 1.66K | F | Common Stock | -362.80K |
2024-02-21 | 2024-02-16 | Kramer Robin | Chief Accounting Officer | 5.92K | 269 | F | Common Stock | -58.93K |
2024-02-21 | 2024-02-16 | Izzar Rachid | Head of Global Product Strat. | 10.01K | 647 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Mcdonnell Michael R | EVP, Chief Financial Officer | 19.41K | 1.10K | F | Common Stock | -241.21K |
2024-02-21 | 2024-02-16 | Mcdonnell Michael R | EVP, Chief Financial Officer | 18.36K | 2.34K | F | Common Stock | -511.99K |
2024-02-21 | 2024-02-16 | Singhal Priya | Head of Development | 5.26K | 173 | F | Common Stock | -37.90K |
2024-02-21 | 2024-02-16 | Murphy Nicole | Head of Pharm Ops and Tech | 9.42K | 196 | F | Common Stock | -42.94K |
2024-02-21 | 2024-02-16 | Murphy Nicole | Head of Pharm Ops and Tech | 9.62K | 856 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Singhal Priya | Head of Development | 5.34K | 819 | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Izzar Rachid | Head of Global Product Strat. | 9.70K | 313 | F | Common Stock | -68.57K |
2024-02-21 | 2024-02-16 | Mcdonnell Michael R | EVP, Chief Financial Officer | 20.51K | 2.15K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Singhal Priya | Head of Development | 5.15K | 108 | S | Common Stock | -23.92K |
2024-02-21 | 2024-02-16 | Singhal Priya | Head of Development | 5.04K | 295 | F | Common Stock | -64.63K |
2024-02-21 | 2024-02-16 | Murphy Nicole | Head of Pharm Ops and Tech | 9.21K | 414 | F | Common Stock | -90.70K |
2024-02-21 | 2024-02-16 | Kramer Robin | Chief Accounting Officer | 6.23K | 127 | F | Common Stock | -27.82K |
2024-02-21 | 2024-02-16 | Gregory Ginger | EVP, Human Resources | 14.31K | 1.51K | M | Common Stock | 0 |
2024-02-21 | 2024-02-16 | Izzar Rachid | Head of Global Product Strat. | 9.37K | 639 | F | Common Stock | -139.99K |
2024-02-21 | 2024-02-16 | Gregory Ginger | EVP, Human Resources | 14.34K | 3.20K | M | Common Stock | 0 |
2024-02-20 | 2024-02-15 | Rowinsky Eric K | Director | 20.63K | 455 | P | Common Stock | 101.26K |
2024-02-13 | 2024-02-09 | Alexander Susan H | EVP Chief Legal Officer | 49.08K | 938 | F | Common Stock | -226.04K |
2024-02-13 | 2024-02-09 | Alexander Susan H | EVP Chief Legal Officer | 50.02K | 2.58K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Izzar Rachid | Head of Global Product Strat. | 7.57K | 621 | F | Common Stock | -149.23K |
2024-02-09 | 2024-02-08 | Murphy Nicole | Head of Pharm Ops and Tech | 7.89K | 2.10K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Gregory Ginger | EVP, Human Resources | 10.12K | 1.64K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Izzar Rachid | Head of Global Product Strat. | 8.19K | 2.04K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Mcdonnell Michael R | EVP, Chief Financial Officer | 15.06K | 2.33K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Kramer Robin | Chief Accounting Officer | 4.69K | 253 | F | Common Stock | -60.80K |
2024-02-09 | 2024-02-08 | Mcdonnell Michael R | EVP, Chief Financial Officer | 14.30K | 765 | F | Common Stock | -183.83K |
2024-02-09 | 2024-02-08 | Alexander Susan H | EVP Chief Legal Officer | 47.45K | 655 | F | Common Stock | -157.40K |
2024-02-09 | 2024-02-08 | Alexander Susan H | EVP Chief Legal Officer | 48.10K | 2.19K | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Kramer Robin | Chief Accounting Officer | 4.94K | 788 | M | Common Stock | 0 |
2024-02-09 | 2024-02-08 | Gregory Ginger | EVP, Human Resources | 9.62K | 498 | F | Common Stock | -119.67K |
2024-02-09 | 2024-02-08 | Murphy Nicole | Head of Pharm Ops and Tech | 7.26K | 638 | F | Common Stock | -153.31K |
2023-12-12 | 2023-12-08 | Kramer Robin | Chief Accounting Officer | 4.32K | 351 | M | Common Stock | 0 |
2023-12-12 | 2023-12-08 | Kramer Robin | Chief Accounting Officer | 4.15K | 170 | F | Common Stock | -40.68K |
2023-12-12 | 2023-12-11 | Singhal Priya | Head of Development | 3.46K | 110 | S | Common Stock | -27.28K |
2023-12-12 | 2023-12-08 | Singhal Priya | Head of Development | 3.57K | 206 | F | Common Stock | -49.29K |
2023-12-12 | 2023-12-08 | Singhal Priya | Head of Development | 3.78K | 426 | M | Common Stock | 0 |
2023-06-28 | 2023-06-26 | Dorsa Caroline | Director | 24.82K | 1.58K | A | Common Stock | 0 |
2023-05-02 | 2023-04-28 | Gregory Ginger | EVP, Human Resources | 8.48K | 2.68K | S | Common Stock | -804.30K |
2023-04-04 | 2023-03-31 | Murphy Nicole | Head of Pharm Ops and Tech | 5.82K | 239 | M | Common Stock | 0 |
2023-04-04 | 2023-03-31 | Murphy Nicole | Head of Pharm Ops and Tech | 5.70K | 116 | F | Common Stock | -32.25K |
2023-03-30 | 2023-03-28 | Singhal Priya | Head of Development | 2.84K | 568 | S | Common Stock | -153.39K |
2023-02-14 | 2023-02-10 | Singhal Priya | Head of Development | 3.86K | 1.21K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | 5.50K | 537 | F | Common Stock | -153.74K |
2023-02-14 | 2023-02-10 | Kramer Robin | Chief Accounting Officer | 3.90K | 228 | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Kramer Robin | Chief Accounting Officer | 3.67K | 262 | F | Common Stock | -75.01K |
2023-02-14 | 2023-02-10 | Kramer Robin | Chief Accounting Officer | 3.93K | 833 | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | 6.03K | 340 | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Gregory Ginger | EVP, Human Resources | 11.67K | 648 | F | Common Stock | -185.52K |
2023-02-14 | 2023-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | 5.33K | 165 | F | Common Stock | -47.24K |
2023-02-14 | 2023-02-10 | Izzar Rachid | Head of Global Product Strat. | 6.35K | 453 | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Izzar Rachid | Head of Global Product Strat. | 6.13K | 220 | F | Common Stock | -62.99K |
2023-02-14 | 2023-02-10 | Izzar Rachid | Head of Global Product Strat. | 6.36K | 1.51K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Izzar Rachid | Head of Global Product Strat. | 5.90K | 462 | F | Common Stock | -132.27K |
2023-02-14 | 2023-02-10 | Izzar Rachid | Head of Global Product Strat. | 5.49K | 642 | F | Common Stock | -183.80K |
2023-02-14 | 2023-02-10 | Gregory Ginger | EVP, Human Resources | 12.81K | 1.13K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Gregory Ginger | EVP, Human Resources | 12.32K | 2.16K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | 5.69K | 685 | F | Common Stock | -196.12K |
2023-02-14 | 2023-02-10 | Kramer Robin | Chief Accounting Officer | 3.83K | 67 | F | Common Stock | -19.18K |
2023-02-14 | 2023-02-10 | Singhal Priya | Head of Development | 3.49K | 372 | F | Common Stock | -106.50K |
2023-02-14 | 2023-02-10 | Gregory Ginger | EVP, Human Resources | 12.26K | 548 | F | Common Stock | -156.89K |
2023-02-14 | 2023-02-10 | Mcdonnell Michael R | EVP, Chief Financial Officer | 8.90K | 1.10K | F | Common Stock | -316.36K |
2023-02-14 | 2023-02-10 | Mcdonnell Michael R | EVP, Chief Financial Officer | 10.00K | 3.26K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Gregory Ginger | EVP, Human Resources | 10.15K | 2.11K | F | Common Stock | -604.09K |
2023-02-14 | 2023-02-10 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 44.92K | 2.74K | F | Common Stock | -783.60K |
2023-02-14 | 2023-02-10 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 47.66K | 701 | F | Common Stock | -200.70K |
2023-02-14 | 2023-02-10 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 48.36K | 1.45K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 46.91K | 764 | F | Common Stock | -218.73K |
2023-02-14 | 2023-02-10 | Murphy Nicole | Head of Pharm Ops and Tech | 6.38K | 2.27K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 47.67K | 2.58K | M | Common Stock | 0 |
2023-02-14 | 2023-02-10 | Kramer Robin | Chief Accounting Officer | 3.57K | 261 | F | Common Stock | -74.72K |
2023-01-27 | 2023-01-25 | Izzar Rachid | Head of Alzheimer's Disease | 4.84K | 1.78K | A | Common Stock | 0 |
2023-01-27 | 2023-01-25 | Gregory Ginger | EVP, Human Resources | 10.16K | 4.45K | A | Common Stock | 0 |
2023-01-27 | 2023-01-25 | Murphy Nicole | Head of Pharm Ops and Tech | 4.11K | 1.34K | A | Common Stock | 0 |
2023-01-27 | 2023-01-25 | Alexander Susan H | EVP Chief Legal Off & Corp Sec | 45.10K | 5.70K | A | Common Stock | 0 |
2022-12-12 | 2022-11-14 | Gregory Ginger | EVP, Human Resources | 5.71K | 5.61K | S | Common Stock | -1.68M |
2022-08-03 | 2022-08-01 | Murphy Nicole | Head of Pharm Ops and Tech | 2.92K | 825 | M | Common Stock | 0 |
2022-08-03 | 2022-08-01 | Murphy Nicole | Head of Pharm Ops and Tech | 2.68K | 243 | F | Common Stock | -50.85K |
2022-08-03 | 2022-08-01 | Murphy Nicole | Head of Pharm Ops and Tech | 2.09K | 76 | F | Common Stock | -15.90K |
2022-08-03 | 2022-08-01 | Murphy Nicole | Head of Pharm Ops and Tech | 2.17K | 255 | M | Common Stock | 0 |
2022-06-17 | 2022-06-15 | Dorsa Caroline | Director | 23.24K | 1.37K | A | Common Stock | 0 |
2022-06-17 | 2022-06-15 | Hawkins William A | Director | 4.19K | 1.37K | A | Common Stock | 0 |
2022-06-17 | 2022-06-15 | Denner Alexander J | Director | 15.10K | 1.37K | A | Common Stock | 0 |
2022-06-17 | 2022-06-15 | Freire Maria C | Director | 2.15K | 1.37K | A | Common Stock | 0 |